GC Medical Science Corporation (KOSDAQ:142280)
South Korea · Delayed Price · Currency is KRW 2,930.00
+30.00 (1.03%)
At close: Aug 11, 2026
GC Medical Science Balance Sheet
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 956.1 | 372.63 | 678.49 | 5,744 | 8,751 | 1,843 |
Short-Term Investments | - | - | - | - | -0 | - |
Trading Asset Securities | - | - | - | - | 2,000 | - |
Cash & Short-Term Investments | 956.1 | 372.63 | 678.49 | 5,744 | 10,751 | 1,843 |
Cash Growth | -45.26% | -45.08% | -88.19% | -46.57% | 483.45% | -59.08% |
Accounts Receivable | 21,582 | 21,059 | 17,480 | 21,070 | 19,891 | 20,967 |
Other Receivables | 0.85 | 0.67 | 356.99 | 293.94 | 915.87 | 109.86 |
Receivables | 21,583 | 21,059 | 17,837 | 21,364 | 20,807 | 21,623 |
Inventory | 17,274 | 17,450 | 18,568 | 14,735 | 15,019 | 27,827 |
Prepaid Expenses | 171.58 | 101.68 | 7.35 | 171.99 | 260.22 | 234.82 |
Other Current Assets | 1,773 | 1,766 | 2,337 | 1,330 | 3,301 | 823.72 |
Total Current Assets | 41,758 | 40,749 | 39,429 | 43,345 | 50,137 | 52,351 |
Property, Plant & Equipment | 43,670 | 44,181 | 45,054 | 42,850 | 41,158 | 40,013 |
Long-Term Investments | 2,592 | 2,578 | 2,218 | 2,647 | 3,036 | 1,815 |
Goodwill | 253.76 | 253.76 | 253.76 | 253.76 | 253.76 | 253.76 |
Other Intangible Assets | 468.27 | 483.93 | 428.07 | 441.8 | 254.64 | 197.92 |
Long-Term Accounts Receivable | 0 | 0 | -0 | 0 | -0 | 0 |
Long-Term Deferred Tax Assets | 1,628 | 1,628 | - | - | - | - |
Long-Term Deferred Charges | 147.84 | - | - | - | - | - |
Other Long-Term Assets | 642.82 | 634.89 | 592.11 | 992.24 | 1,631 | 998.13 |
Total Assets | 91,161 | 90,510 | 87,975 | 90,529 | 96,471 | 95,629 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 11,043 | 12,351 | 9,613 | 11,444 | 10,401 | 12,747 |
Accrued Expenses | 2,186 | 1,602 | 1,793 | 1,926 | 3,245 | 3,662 |
Short-Term Debt | 12,756 | 10,580 | 10,221 | 15,707 | 2,000 | 29,100 |
Current Portion of Long-Term Debt | - | - | - | - | 416 | 588 |
Current Portion of Leases | 1,237 | 1,227 | 1,381 | 1,607 | 1,122 | 1,134 |
Current Income Taxes Payable | 3.33 | 8.49 | - | 0.49 | 89.96 | 1.02 |
Other Current Liabilities | 8,576 | 9,623 | 14,115 | 15,844 | 22,214 | 1,638 |
Total Current Liabilities | 35,801 | 35,392 | 37,123 | 46,528 | 39,488 | 48,870 |
Long-Term Debt | - | - | - | - | 12,741 | - |
Long-Term Leases | 5,429 | 5,647 | 5,752 | 5,265 | 7,122 | 6,159 |
Pension & Post-Retirement Benefits | 2,833 | 2,624 | 1,116 | 1,356 | 1,088 | 1,126 |
Other Long-Term Liabilities | 498.29 | 481.91 | 555.12 | 456.27 | 381.17 | 1,538 |
Total Liabilities | 44,561 | 44,145 | 44,546 | 53,606 | 60,820 | 57,693 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 10,871 | 10,871 | 10,871 | 10,559 | 10,559 | 10,559 |
Additional Paid-In Capital | 14,842 | 14,842 | 26,642 | 23,783 | 23,783 | 38,240 |
Retained Earnings | 18,992 | 18,848 | 4,115 | 571.52 | -672.87 | -12,225 |
Treasury Stock | - | - | -414.12 | -414.12 | -414.12 | -538.02 |
Comprehensive Income & Other | -188.41 | -202.46 | -0 | -0 | -0 | 79.5 |
Total Common Equity | 44,517 | 44,359 | 41,214 | 34,499 | 33,255 | 36,115 |
Minority Interest | 2,083 | 2,007 | 2,214 | 2,424 | 2,396 | 1,821 |
Shareholders' Equity | 46,600 | 46,365 | 43,429 | 36,923 | 35,651 | 37,936 |
Total Liabilities & Equity | 91,161 | 90,510 | 87,975 | 90,529 | 96,471 | 95,629 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | 19,422 | 17,454 | 17,353 | 22,580 | 23,401 | 36,981 |
Net Cash (Debt) | -18,466 | -17,081 | -16,675 | -16,836 | -12,650 | -35,139 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share | -690.93 | -640.31 | -623.49 | -629.11 | -600.13 | -1667.93 |
Filing Date Shares Outstanding | 21.74 | 21.74 | 21.71 | 21.08 | 21.08 | 21.07 |
Total Common Shares Outstanding | 21.74 | 21.74 | 21.71 | 21.08 | 21.08 | 21.07 |
Working Capital | 5,957 | 5,358 | 2,306 | -3,182 | 10,649 | 3,481 |
Book Value Per Share | 2047.53 | 2040.23 | 1898.68 | 1636.40 | 1577.38 | 1714.26 |
Tangible Book Value | 43,795 | 43,621 | 40,533 | 33,804 | 32,746 | 35,663 |
Tangible Book Value Per Share | 2014.32 | 2006.31 | 1867.27 | 1603.41 | 1553.26 | 1692.82 |
Land | 198.49 | 198.49 | 198.49 | 85.64 | 85.64 | 85.64 |
Buildings | 27,116 | 27,115 | 23,341 | 22,427 | 19,534 | 19,534 |
Machinery | 24,599 | 24,510 | 22,576 | 20,627 | 21,227 | 20,713 |
Construction In Progress | 749.11 | 418.35 | 5,169 | 3,880 | 2,279 | 7.6 |